| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |